All News

AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration
Ref: GlobeNewswire
Tags: Press ReleaseApplied Genetic Technologies Biogen Clinical Research (R&D) Corporate Affairs LicensingrAAV2tYF-CB-hRS1
Haidian District People’s Court in Beijing Issues Injunction Order Restraining Aihua Pan from Using Business License and Corporate Seal of Sinovac Beijing
Ref: Business Wire
Tags: Press ReleaseSinovacChina Corporate Affairs
Killing the liver-stage malaria parasite with baculovirus: a drug discovery approach
Ref: Kanazawa University
Tags: Press Release Clinical Research (R&D)artemisinin interferon-alpha primaquine
Santhera Launches Placement of Shares through Accelerated Bookbuilding
Ref: GlobeNewswire
Tags: Press ReleaseSanthera Corporate Affairs
The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes
Ref: Business Wire
Tags: Press ReleaseThe Medicines Company Corporate Affairs
Big Pharma's likely defeat on 'donut hole' foreshadows treacherous 2019
Ref: Washington Examiner
Tags: NewsPointsLilly Marketing & Sales
Researchers collaborating with National Institutes of Health to develop nonopioid drug for chronic pain
Ref: Virginia Tech
Tags: Press ReleasePain Management NIHClinical Research (R&D)ML351
Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Ref: GlobeNewswire
Tags: Press ReleaseSynthorx Corporate Affairs
Hemispherx Biopharma Issues Letter to Stockholders
Ref: GlobeNewswire
Tags: Press ReleaseHemispherx Corporate AffairsAmpligen
Sunshine Biopharma Signs an Agreement with Crocus Laboratories for Manufacturing of Adva-27a Anticancer Drug
Ref: Accesswire
Tags: Press ReleaseSunshine BiopharmaPancreatic Cancer Corporate AffairsAdva-27a